PTPN1 and Glucose intolerance: In addition to direct PTP-1B activity inhibition and molecular docking studies, some extracts and compounds were assessed to improve glucose and lipid metabolism in vivo, such as lowering blood glucose levels, improved insulin resistance and glucose intolerance, and improved lipid profile.